Immunogenicity and safety of mixed COVID-19 vaccine regimens in patients with immune-mediated inflammatory diseases: a single-centre prospective cohort study

Ruth Ann Marrie,John Kim,Christine Mesa,Catherine Card,Charles N Bernstein,Carol A Hitchon,Sheila F O’Brien

doi:10.1136/bmjopen-2022-071397

Immunogenicity and safety of mixed COVID-19 vaccine regimens in patients with immune-mediated inflammatory diseases: a single-centre prospective cohort study

Ruth Ann Marrie, John Kim + Show 5 more

Open Access

https://doi.org/10.1136/bmjopen-2022-071397

Copy DOI

Journal: BMJ Open	Publication Date: May 1, 2023
Citations: 3	License type: open-access

Affiliation: University of Manitoba, Public Health Agency of Canada, Canadian Blood Services

#mRNA Vaccines #Immune-mediated Inflammatory Diseases + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

ObjectiveAmong persons with immune-mediated inflammatory diseases (IMIDs) who received SARS-CoV-2 vaccines, we compared postvaccine antibody responses and IMID disease activity/states.DesignSingle-centre prospective cohort study.SettingSpecialty ambulatory clinics in central Canada.ParticipantsPeople with inflammatory...

Full Text